Get startedLog in
    Picture of Apellis Pharmaceuticals logo

    APLS — Apellis Pharmaceuticals News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousLarge CapHigh Flyer
    All News

    Brief: Apellis Pharmaceuticals Q4 Basic EPS USD -0.73

    Picture of Apellis Pharmaceuticals logoApellis Pharmaceuticals
    27/02/2024 12:05
    Feb 27 (Reuters) - Apellis Pharmaceuticals Q4 operating income USD -84.518
million.
* Q4 product revenue USD 138.655 million
* Q4 operating expenses USD 230.895 million
* Q4 net income USD -88.576 million

    Recent news on Apellis Pharmaceuticals

    See all news